Primary cutaneous anaplastic large-cell lymphoma: Complete remission for 13 years after denileukin diftitox
Main Authors: | Daniel J. Lewis, BA, Harry Dao, Jr.MD, Priyadharsini Nagarajan, MD, PhD, Madeleine Duvic, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-11-01
|
Series: | JAAD Case Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512617301431 |
Similar Items
-
Denileukin diftitox for the treatment of cutaneous T-cell lymphoma
by: David Kaminetzky, et al.
Published: (2008-12-01) -
Role of denileukin diftitox in the treatment of persistent or recurrent cutaneous T-cell lymphoma
by: Frederick Lansigan, et al.
Published: (2010-02-01) -
Advanced-Stage Primary Cutaneous T-Cell Lymphoma Treated with Bexarotene and Denileukin Diftitox
by: Iván Cervigón-González, et al.
Published: (2011-02-01) -
Denileukin Diftitox (Ontak) as Maintenance Therapy for Peripheral T-Cell Lymphomas: Three Cases with Sustained Remission
by: Alejandra C. Fuentes, et al.
Published: (2015-01-01) -
Production of Recombinant Denileukin Diftitox: Assessment in the Lab-scale Bioreactor
by: Seyed Morteza Robatjazi, et al.
Published: (2019-08-01)